Novartis AG has hauled Torrent Pharmaceuticals Ltd. to court in India over the alleged infringement of a patent pertaining to its blockbuster heart failure therapy Entresto (sacubitril/valsartan).
The Swiss multinational, however, appears to be facing a parallel challenge with the Indian firm moving the country’s Intellectual Property...







